TMEM18 and obesity disorder: Thus, indicating that the attenuation of the obesity risk and a reduction in BMI of the TMEM18 rs939583 homozygotes (TT) carriers could be achieved through engagement in PA for at least (minimum) 30 min/week with further BMI reduction when engaging in PA for >90 min/week.